New Study Proves Vitamin K2 Slows Heart Disease (Really?)

Study Overview and Initial Reactions00:00:00

The video introduces a circulation paper regarding Vitamin K2 and clogged arteries. One expert expresses disappointment while the other is excited. The study was a double-blind, placebo-controlled trial involving 400 participants with high calcium scores who received 720 micrograms of K2 and 25 micrograms of D3 over one year.

Results and Plaque Composition00:02:40

Of the participants, 143 underwent angiography for detailed plaque analysis. The study concluded that K2 and D3 reduced calcium score progression over 24 months without increasing non-calcified plaque volume. The speakers discuss whether this indicates plaque stabilization or if the lack of soft plaque reduction makes the results inconclusive.

Critical Analysis and Flaws00:05:46

The experts critique the study design, specifically the selection criteria for the 143 participants who received contrast dye. They debate the definition of 'soft plaque' versus 'non-calcified plaque' and discuss low-density non-calcified plaque, which the study did not specifically measure.

Conclusion and Recommendations00:10:00

The speakers conclude that while the study does not disprove K2's benefits, it is not definitive proof either. They emphasize that lifestyle factors like diet, exercise, and sleep are more important than supplements. Both agree they will continue to recommend K2, noting that lifestyle beats any supplement.